Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Progyny, Inc. (PGNY)

34.6   0.39 (1.14%) 09-27 16:00
Open: 34.49 Pre. Close: 34.21
High: 35.06 Low: 34.02
Volume: 963,459 Market Cap: 3,301(M)

Technical analysis

as of: 2023-09-27 4:21:25 PM
Short-term rate:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Mid-term rate:       
Target: Six months: 42.31     One year: 44.72
Support: Support1: 32.89    Support2: 27.36
Resistance: Resistance1: 36.22    Resistance2: 38.29
Pivot: 34.94
Moving Average: MA(5): 33.68     MA(20): 35.57
MA(100): 37.92     MA(250): 35.79
MACD: MACD(12,26): -1.2     Signal(9): -1.1
Stochastic oscillator: %K(14,3): 22.4     %D(3): 12.4
RSI: RSI(14): 42.1
52-week: High: 45.97  Low: 28.03
Average Vol(K): 3-Month: 694 (K)  10-Days: 891 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ PGNY ] has closed above bottom band by 43.3%. Bollinger Bands are 13.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 35.11 - 35.25 35.25 - 35.4
Low: 33.68 - 33.82 33.82 - 33.97
Close: 34.36 - 34.61 34.61 - 34.88

Company Description

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Headline News

Wed, 27 Sep 2023
Progyny, Inc. Shows Impressive Performance and Analyst ... - Best Stocks

Wed, 27 Sep 2023
Deepwater Asset Management LLC Has $10.81 Million Stock ... - MarketBeat

Wed, 27 Sep 2023
Analysts Bullish on Progynys Future Performance - Best Stocks

Tue, 26 Sep 2023
Institutional Investor FDx Advisors Inc. Expands Position in Progyny ... - Best Stocks

Tue, 26 Sep 2023
Progyny (PGNY): Unveiling Its True Value -

Sun, 17 Sep 2023
Progyny, Inc. (NASDAQ:PGNY) Given Consensus Recommendation ... - MarketBeat

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Health Information Services
Shares Out. 95 (M)
Shares Float 83 (M)
% Held by Insiders 1.1 (%)
% Held by Institutions 100.9 (%)
Shares Short 5,410 (K)
Shares Short P.Month 5,720 (K)

Stock Financials

EPS 0.46
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.92
Profit Margin (%) 5.1
Operating Margin (%) 4.6
Return on Assets (ttm) 4.8
Return on Equity (ttm) 12.6
Qtrly Rev. Growth 43.2
Gross Profit (p.s.) 1.75
Sales Per Share 10.03
EBITDA (p.s.) 0.48
Qtrly Earnings Growth 66.6
Operating Cash Flow 169 (M)
Levered Free Cash Flow 145 (M)

Stock Valuations

PE Ratio 73.61
PEG Ratio 5.2
Price to Book value 7.01
Price to Sales 3.44
Price to Cash Flow 19.48

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.